Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cyproheptadine and Chlorpromazine Effects on Spasticity

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Alberta
ClinicalTrials.gov Identifier:
NCT01509885
First received: January 10, 2012
Last updated: November 16, 2012
Last verified: November 2012